« Previous
Next »
Subjects
- Psoriasis -- drug therapy[remove]4
- Humans2
- Immunologic Factors -- adverse effects2
- Immunologic Factors -- economics2
- Immunologic Factors -- therapeutic use2
- United States2
- Adalimumab -- therapeutic use1
- Arsenic -- adverse effects1
- Benchmarking1
- Certolizumab Pegol -- therapeutic use1
- Clinical Trials as Topic1
- Comparative Effectiveness Research1
- Cost-Benefit Analysis1
- Etanercept -- therapeutic use1
- Hyperpigmentation -- etiology1
- Immunomodulation1
- Interleukin-12 -- antagonists & inhibitors1
- Interleukin-171
- Interleukin-23 -- antagonists & inhibitors1
- Ointments -- therapeutic use1